US Patent Issued to Evaxion Biotech on Jan. 28 for "Chimeric proteins for inducing immunity towards infection with S. aureus" (Danish Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,110, issued on Jan. 28, was assigned to Evaxion Biotech A/S (Horsholm, Denmark).

"Chimeric proteins for inducing immunity towards infection with S. aureus" was invented by Niels Iversen Moller (Horsholm, Denmark), Andreas Holm Mattsson (Horsholm, Denmark) and Jens Kringelum (Horsholm, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is chimeric polypeptides derived from S. aureus proteins having SEQ ID NOs: 1-9 and 139-146. The chimeric polypeptides are useful as immunogens for providing protective immunity against S. aureus infection. Also disclosed are compositions, methods of treatment and prophylaxis, nucleic acids and vectors co...